SF1752

Purpose

• Expand health coverage to include over-the-counter contraceptive drugs, devices, and products and require coverage by insurers and medical assistance programs.
• Clarify and standardize key terms related to contraception, prescription vs. OTC products, and how coverage decisions should be made.
• Add reporting requirements to track this coverage and its effects.

Main Provisions

• Definitions added or amended in Minnesota Statutes:
  • Contraceptive method: Any FDA-approved drug, device, or product meant to prevent unintended pregnancy, whether prescription or over-the-counter.
  • Contraceptive service: Services and related activities (consultation, examination, procedures, education, counseling, follow-up, and management of side effects) related to preventing unintended pregnancy, excluding vasectomies.
  • Medical necessity: Factors considered when deciding coverage, including severity of side effects, how permanent or reversible a method is, and the patient’s ability to use the method as prescribed.
  • Over-the-counter contraceptive (OTC contraceptive): An FDA-approved drug, device, or product that does not require a prescription.
  • Prescription contraceptive: An FDA-approved drug, device, or product that requires a prescription.
  • Therapeutic equivalence version: A drug, device, or product that provides the same clinical effect and safety as another version, meeting criteria for active ingredient amount, dosage form, route of administration, labeling, and manufacturing standards; can be substituted when appropriate if it is bioequivalent.
  • Pharmacy: Definition aligned with existing law.
• Coverage requirement:
  • Insurers and medical assistance must cover OTC contraceptives (drugs, devices, and products).
  • Coverage decisions for OTC contraceptives are framed with the same concepts used for prescription contraceptives, including considerations of medical necessity.
• Exclusion:
  • Contraceptive service definitions explicitly exclude vasectomies.
• Reporting:
  • Adds reporting requirements and amends related statutes to track coverage and implementation (Minnesota Statutes 2024 sections 62Q.522 and 256B.0625, subdivision 13).

Changes to Existing Law

• Adds comprehensive definitions related to contraception (method, service, OTC vs. prescription, medical necessity, therapeutic equivalence).
• Establishes a statutory mandate for coverage of OTC contraceptives by private insurers and public medical assistance programs.
• Clarifies what constitutes a contraceptive service (excluding vasectomies) and how medical necessity applies to contraception coverage.
• Introduces a formal reporting requirement to monitor and report on implementation and impact.

Notable Effects and Implications

• Greater access to OTC contraception through insurance coverage, potentially reducing out-of-pocket costs for many individuals.
• Clearer framework for when and how OTC contraceptives are covered alongside prescription options.
• Encourages the use of therapeutically equivalent products where appropriate, emphasizing bioequivalence and proper labeling/manufacturing standards.
• Vasectomies remain outside the scope of “contraceptive service” under this definition.

Notable Exclusions

• Vasectomies are excluded from the defined contraceptive services in this bill.

Practical Considerations

• The bill emphasizes access and affordability of contraception by ensuring OTC options are covered, which may affect payer policies and formulary decisions.
• The definitions aim to reduce ambiguity in coverage decisions between OTC and prescription contraceptives.

Relevant Terms - over-the-counter contraceptive (OTC contraceptive) - prescription contraceptive - contraceptive method - contraceptive service - medical necessity - therapeutic equivalence version - bioequivalence - FDA - pharmacy - insurers - medical assistance - vasectomies - coverage - reporting - Minnesota Statutes 62Q.522 - Minnesota Statutes 256B.0625